Oscar Health COO stepping down

Oscar Health’s Chief Operating Officer Meghan Joyce is resigning from her role, effective April 10.

The news was announced in a filing with the Securities and Exchange Commission (SEC). Oscar Health, based in New York, is a technology-forward healthcare company founded by Joshua Kushner and Mario Schlosser. The company went public in 2021 and has made several major partnerships with other healthcare insurance players, such as Cigna.

Joyce, who also served as executive vice president of platform at Oscar, is leaving the company to become CEO of a new venture, the document states. The +Oscar technology platform and business line will report directly to co-founder and CEO, Mario Schlosser, after Joyce’s departure. In addition, Chief Insurance Officer Alessandrea Quane will assume oversight of insurance operations.

Joyce has entered into a consulting agreement with Oscar Health and its subsidiary, Oscar Management Corporation, in which she will continue to support the company. She will receive a monthly consulting fee of $8,333, but will not be entitled to an annual bonus award for the company’s performance year 2022 and thereafter.

The company offers insurance for individuals, families, small group plans (in partnership with Cigna), and Medicare Advantage plans. 

The company offers members of its plans virtual urgent and primary care, where the member can talk to or message a doctor and get a diagnosis, a new prescription, or a prescription refill in about 30 minutes. Oscar's virtual urgent care program allows members to talk to a doctor about urgent health issues for free, anytime 24-hours a day. This can help eliminate some trips to a doctor's office, so it eliminates copays and lowers healthcare costs.

Related Oscar Health Content:

Oscar Health partners with Emory on health insurance and care offering

Oscar Health to launch IPO

Cigna and Oscar Health offer new small business health plan

Cigna partners with health insurer startup Oscar for small biz plans

Find more healthcare economics news

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.